AB-PINACA is a compound that was first identified as a component of synthetic cannabis products in Japan in 2012. It was originally developed by Pfizer in 2009 as an analgesic medication.
The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications.
POWER: light | normal | strong | very strong
Systematic (IUPAC) name: N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole-3-carboxamide
CAS Number: 1445752-09-9
Molar mass: 330.43 g/mol